SEARCH

SEARCH BY CITATION

References

  • Abbruzzese, J. L., C. F. Gholson, K. Daugherty, E. Larson, R. Dubrow, R. Berlin & B. Levin: A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer. Pancreas 1992, 7, 165171.
  • Abou-Saif, A., J. Lei, T. J. McDonald, S. Chakrabarti, I. Waxman, H. Shojamanesh, D. S. Schrump, D. E. Kleiner, F. Gibril & R. T. Jensen: A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer. Gastroenterology 2001, 120, 12711278.
  • Abrahamsson, H.: Gastrointestinal motility in patients with the irritable bowel syndrome. Scand. J. Gastroenterol. 1987, 130, 2126.
  • Adler, G., C. Beglinger, U. Braun, M. Reinshagen, I. Koop, A. Schafmayer, L. Rovati & R. Arnold: Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 1991, 100, 537543.
  • Adler, G., T. Hupp & H. F. Kearn: Course and spontaneous regression of acute pancreatitis in the rat. Virchows Arch. A Pathol. Anat. Histol. 1979, 382, 3147.
  • Amaral, J., Z. L. Xiao, Q. Chen, P. Yu, P. Biancani & J. Behar: Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology 2001, 120, 506511.
  • Attoub, S., S. Levasseur, M. Buyse, H. Goiot, J. P. Laigneau, L. Moizo, F. Hervatin, B. Y. LeMarchand & J. M. Lewin: Physiological role of cholecystokinin B/gastrin receptor in leptin secretion. Endocrinology 1999, 140, 44064410.
  • Axelson, J., M. Ekelund, R. Håkanson & F. Sundler: Gastrin and the vagus interact in the trophic control of the rat oxyntic mucosa. Regul. Pept. 1988, 22, 237243.
  • Baldwin, G. S.: The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J. Gastroenterol. Hepatol. 1995, 10, 215232.
  • Baldwin, G. S. & A. Shulkes: Gastrin as an autocrine growth factor in colorectal carcinoma: implications for therapy. World J. Gastroenterol. 1998a, 4, 461463.
  • Baldwin, G. S. & A. Shulkes: Gastrin, gastrin receptors and colorectoral carcinoma. Gut 1998b, 42, 581584.
  • Ballinger, A., L. McLoughlin, S. Medbak & M. Clark: Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin. Sci. (Lond) 1995, 89, 375381.
  • Ballinger, A. B. & M. L. Clark: L-phenylalanine releases cholecystokinin (CCK) and is associated with reduced food intake in humans: evidence for a physiological role of CCK in control of eating. Metabolism 1994, 43, 735738.
  • Bardram, L., P. Thomsen & F. Stadil: Gastric endocrine cells in omeprazole treated and untreated patients with Zollinger-Ellison syndrome. Digestion 1986, (Suppl 1) 35, 116122.
  • Barr, R. G., J. N. Agnesi & C. R. Schaub: Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults. Radiology 1997, 204, 105111.
  • Beglinger, C.: Potential role of cholecystokinin in the development of acute pancreatitis. Digestion 1999, 60, 6163.
  • Beglinger, C., L. Degen, D. Matzinger, M. D'Amato & J. Drewe: Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Amer. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280, 11491154.
  • Behar, J.: Clinical aspects of gallbladder motor function and dysfunction. Curr. Gastroenterol. Rep. 1999, 1, 9194.
  • Behar, J., K. Y. Lee, W. R. Thompson & P. Biancani: Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989, 97, 14791484.
  • Behr, T. M. & M. P. Behe: Cholecystokinin-B/gastrin receptor–Targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin. Nucl. Med. 2002, 32, 97109.
  • Beltinger, J., P. Hildebrand, J. Drewe, A. Christ, K. Hlobil, U. Ritzel, M. D'Amato, L. Rovati & C. Beglinger: Effects of spiroglumide, a gastrin receptor antagonist, on acid secretion in humans. Eur. J. Clin. Invest. 1999, 29, 153159.
  • Björkqvist, M., P. Norlén, N. Kitano, D. Chen, C. M. Zhao, C. D. DelaCour, C. Gagnemo-Persson & R. Håkanson: Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats. Pharmacology & Toxicology 2001, 89, 208213.
  • Borch, K., H. Renvall & G. Liedberg: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985, 88, 638648.
  • Bordi, C., G. Cocconi, R. Togni, P. Vezzadini & G. Missale: Gastric endocrine cell proliferation. Association with Zollinger- Ellison syndrome. Arch. Pathol. 1974, 98, 274278.
  • Bordi, C., T. D'Adda, C. Azzoni & G. Ferraro: Pathogenesis of ECL cell tumors in humans. Yale J. Biol. Med. 1999, 71, 273284.
  • Bordi, C., T. D'Adda, C. Azzoni, F. P. Pilato & P. Caruana: Hypergastrinemia and gastric enterochromaffin-like cells. Amer. J. Surg. Pathol. 1995, 19, S8S19.
  • Bordi, C., F. Pilato, G. Carfagna, C. Ferrarari, T. D'Adda, R. Sivelli, A. Bertele & G. Missale: Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis. Digestion 1986, 35, 130143.
  • Bourassa, J., J. Laine, M. L. Kruse, M. C. Gagnon, E. Calvo & J. Morisset: Ontogeny and species differences in the pancreatic expression and localization of the CCKA receptors. Biochem. Biophys. Res. Comm. 1999, 260, 820828.
  • Brett, B. T., S. C. Smith & C. V. Bouvier: A phase II study of gastrimmune in advanced pancreatic cancer. Gut 2000, 46, 17.
  • Brinton, L. A., G. Gridley, Z. Hrubeck, R. Hoover & J. F. Fraumeni, Jr.: Cancer risk following pernicious anaemia. Brit. J. Cancer 1989, 89, 810813.
  • Bucceri, A. M., A. E. Calogero & A. Brogna: Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics. Elsevier Sci. 2002, 13, 123128.
  • Cadiot, G., T. Lehy, P. Ruszniewski, S. Bonfils & M. Mignon: Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig. Dis. Sci. 1993, 38, 13071317.
  • Cadiot, G., C. Vissuzaine, F. Potet & M. Mignon: Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig. Dis. Sci. 1995, 40, 12751278.
  • Calam, J.: Helicobacter pylori modulation of gastric acid. Yale J. Biol. Med. 1999, 72, 195202.
  • Calam, J., A. Ellis & G. J. Dockray: Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J. Clin. Invest. 1982, 69, 218225.
  • Cann, P. A., L. C. Rovati, H. L. Smart, R. C. Spiller & P. J. Whorwell: Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study. Ann. N. Y. Acad. Sci. 1994, 713, 449450.
  • Cao, G., L. Zhu & D. Liao: The influence of vagotomy on stomach endocrine cells in rat. Hua Xi Yi Ke Da Xue Xue Bao 1991, 22, 282286.
  • Caplin, M., K. Khan, S. Grimes, D. Michaeli, K. Savage, R. Pounder & A. Dhillon: Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines. Dig. Dis. Sci. 2001, 46, 13561366.
  • Caplin, M., K. Khan, K. Savage, J. Rode, A. Varro, D. Michaeli, S. Grimes, B. Brett, R. Pounder & A. Dhillon: Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J. Hepatol. 1999, 30, 519526.
  • Chen, D., X. Q. Ding, J. F. Rehfeld & R. Håkanson: Endogenous gastrin and cholecystokinin do not promote growth of rat liver. Scand. J. Gastroenterol. 1994, 29, 688692.
  • Chen, D., C. M. Zhao, P. Norlén, M. Bjorkqvist, X. Q. Ding, N. Kitano & R. Håkanson: Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study. Cell Tissue Res. 2000, 299, 8195.
  • Chen, P. F., A. Nimeri, Q. H. Pham, J. N. Yuh, J. R. Gusz & R. S. Chung: The clinical diagnosis of chronic acalculous cholecystitis. Surgery 2001, 130, 578581.
  • Chey, W. Y., H. O. Jin, M. H. Lee, S. W. Sun & K. Y. Lee: Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Amer. J. Gastroenterol. 2001, 96, 14991506.
    Direct Link:
  • Chu, M., F. C. Nielsen, L. Franzen, J. F. Rehfeld, J. J. Holst & K. Borch: Effect of endogenous hypergastrinemia on gastrin receptor expressing human colon carcinoma transplanted to athymic rats. Gastroenterology 1995, 109, 14151420.
  • Chua, A. S., T. G. Dinan, L. C. Rovati & P. W. Keeling: Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann. N. Y. Acad. Sci. 1994, 713, 298299.
  • Ciccotosto, G. D., A. McLeish, K. J. Hardy & A. Shulkes: Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995, 109, 11421153.
  • Clerc, P., M. Dufresne, C. Saillan, E. Chastre, T. Andre, C. Escrieut, K. Kennedy, N. Vaysse, C. Gespach & D. Fourmy: Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon. Int. J. Cancer 1997, 72, 931936.
  • Coupe, M., H. Rees, C. J. Springer, A. E. Bishop, J. A. Morris, J. M. Polak & J. Calam: Gastric enterochromaffin-like (ECL) cells in hypergastrinaemic duodenal ulcer disease. Gut 1990, 31, 144147.
  • Creutzfeldt, W.: The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988, 39, 6179.
  • Creutzfeldt, W.: Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. New. Engl. J. Med. 2001, 345, 65.
  • Creutzfeldt, W. & R. Lamberts: Is hypergastrinemia dangerous to man?. Scand. J. Gastroenterol. Suppl. 1991, 180, 179191.
  • Cui, G., G. Qvigstad, S. Falkmer, A. K. Sandvik, S. Kawase & H. L. Waldum: Spontaneous ECLomas in cotton rats (Sigmodon hispidus): tumours occurring in hypoacidic/hypergastrinaemic animals with normal parietal cells. Carcinogenesis 2000, 21, 2327.
  • D'Adda, T., V. Corleto, F. P. Pilato, M. T. Baggi, F. Robutti, G. Delle Fave & C. Bordi: Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology 1990, 99, 1726.
  • Degen, L., D. Matzinger, J. Drewe & C. Beglinger: The effect of cholecytokinin in controlling appetite and food intake in humans. Peptides 2001, 22, 12651269.
  • Delle Fave, G., M. Marignani, A. Moretti, G. D'Ambra, G. Martino & B. Annibale: Hypergastrinemia and enterochromaffin-like cell hyperplasia. Yale J. Biol. Med. 1998, 71, 291301.
  • DeTullio, P., J. Delarge & B. Pirotte: Therapeutic and chemical developments of cholecystokinin receptor ligands. Exp. Opin. Invest. Drugs 2000, 9, 129136.
  • Devlin, M. J., B. T. Walsh, J. L. Guss, H. R. Kissileff, R. A. Liddle & E. Petkova: Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Amer. J. Clin. Nutr. 1997, 65, 114120.
  • DeWeerth, A., T. VonSchrenck, M. Lohr, S. Mirau, H. Greten & H. Kalthoff: Human pancreatic cancer cell lines express the CCKB receptor. Hepatogastroenterology 1999, 46, 472478.
  • Dickinson, C. J.: Relationship of gastrin processing to colon cancer (Editorial). Gastroenterology 1995, 109, 13841388.
  • Ding, W. Q., S. M. Kuntz & L. J. Miller: A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron. Cancer Res. 2002, 62, 947952.
  • Dlugosz, J., U. R. Folsch, A. Czajkowski & A. Gabryelewicz: Feedback regulation of stimulated pancreatic enzyme secretion during intraduodenal perfusion of trypsin in man. Eur. J. Clin. Invest. 1988, 18, 267272.
  • Dockray, G. J., A. Varro, R. Dimaline & T. Wang: The gastrins: their production and biological activities. Annu. Rev. Physiol. 2001, 63, 119139.
  • Dore, M. P. & D. Y. Graham: Pathogenesis of duodenal ulcer disease: the rest of the story. Baillieres Best Pract. Res. Clin. Gastroenterol. 2000, 14, 97107.
  • Edkins, J. S.: On the chemical mechanism of gastric secretion. Proc. R. Soc. Lond. [Biol]. 1905, 76, 376.
  • Eissele, R., I. Koop, M. Schaar, H. Koop & R. Arnold: Role of cholecystokinin in the control of gastric somatostatin in the rat: in vivo and in vitro studies. Regul. Pept. 1991, 32, 333340.
  • Eissele, R., H. Patberg, H. Koop, W. Krack, W. Lorenz, A. T. McKnight & R. Arnold: Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 1992, 103, 15961601.
  • Ekman, L., E. Hansson, N. Havu, E. Carlsson & C. Lundberg: Toxicological studies on omeprazole. Scand. J. Gastroenterol. 1985, (Suppl 108) 20, 5369.
  • El-Omar, E. M., I. D. Penman, J. E. Ardill, R. S. Chittajallu, C. Howie & K. E. McColl: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995, 109, 681691.
  • Ellison, E. H. & S. D. Wilson: The Zollinger-Ellison syndrome: Re-appraisal and evaluation of 260 registered cases. Ann. Surg. 1964, 160, 512530.
  • Feinle, C., O. Meier, B. Otto, M. D'Amato & M. Fried: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48, 347355.
  • Feurle, G. E.: Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut 1994, 35, 275277.
  • Fisher, W. E., P. Muscarella, L. G. Boros & W. J. Schirmer: Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma. Int. J. Pancreatol. 1998, 24, 169180.
  • Fourmy, D., A. Zahidi, R. Fabre, M. Guidet, L. Pradayrol & A. Ribet: Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. Eur. J. Biochem. 1987, 165, 683692.
  • French, S. J., A. Bergin, C. P. Sepple, N. W. Read & L. Rovati: The effects of loxiglumide on food intake in normal weight volunteers. Int. J. Obes. Relat. Metab. Disord. 1994, 18, 738741.
  • Fried, M., U. Erlacher, W. Schwizer, C. Lochner, J. Koerfer, C. Beglinger, J. B. Jansen, C. B. Lamers, F. Harder, A. Bischof-Delaloye, G. A. Stalder & L. Rovati: Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991, 101, 503511.
  • Friis-Hansen, L., F. Sundler, Y. Li, P. J. Gillespie, T. L. Saunders, J. K. Greenson, C. Owyang, J. F. Rehfeld & L. C. Samuelson: Impaired gastric acid secretion in gastrin-deficient mice. Amer. J. Physiol. 1998, 274, G561G568.
  • Geracioti, T. D., Jr., M. A. Kling, J. R. Joseph-Vanderpool, S. Kanayama, N. E. Rosenthal, P. W. Gold & R. A. Liddle: Meal-related cholecystokinin secretion in eating and affective disorders. Psychopharmacol. Bull. 1989, 25, 444449.
  • Geracioti, T. D., Jr., R. A. Liddle: Impaired cholecystokinin secretion in bulimia nervosa. New. Engl. J. Med. 1988, 319, 683688.
  • Gibril, F., L. T. Curtis, B. Termanini, M. K. Fritsch, I. A. Lubensky, J. L. Doppman & R. T. Jensen: Primary cardiac gastrinoma causing Zollinger-Ellison syndrome. Gastroenterology 1997, 112, 567574.
  • Goetze, J. P., F. C. Nielsen, F. Burcharth & J. F. Rehfeld: Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer 2000, 88, 24872494.
  • Gorelick, F. S. & T. Otani: Mechanisms of intracellular zymogen activation. Bailliere's Best Practice-Research. Clin. Gastroenterol. 1999, 13, 227240.
  • Gregory, R. A. & H. J. Tracy: The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964, 5, 103117.
  • Guo, Y. S. & C. M. Townsend, Jr.: Roles of gastrointestinal hormones in pancreatic cancer. J. Hepatobiliary Pancreat. Surg. 2000, 7, 276285.
  • Halgreen, H., N. T. Pederssen & H. Worning: Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand. J. Gastroenterol. 1986, 21, 104108.
  • Harrison, J. D., J. A. Jones & D. L. Morris: The effect of the gastrin receptor antagonist proglumide on survival in gastric carcinoma. Cancer 1990, 66, 14491452.
  • Havu, N.: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986, (Suppl 1)35, 4255.
  • Helander, H. F.: Oxyntic mucosa histology in omeprazole treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome. Digestion 1986, (Suppl 1)35, 123129.
  • Hellmich, M. R., X. L. Rui, H. L. Hellmich, R. Y. Fleming, B. M. Evers & C. M. Townsend, Jr.: Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J. Biol. Chem. 2000, 275, 3212232128.
  • Henwood, M., P. A. Clarke, A. M. Smith & S. A. Watson: Expression of gastrin in developing gastric adenocarcinoma. Brit. J. Surg. 2001, 88, 564568.
  • Hildebrand, P. & C. Beglinger: Role of CCK in gastrointestinal function. Regul. Pept. Lett. 1994, 6, 710.
  • Hinkle, K. L. & L. C. Samuelson: Lessons from genetically engineered animal models. III. Lessons learned from gastrin gene deletion in mice. Amer. J. Physiol. 1999, 277, G500G505.
  • Hogenauer, C., R. L. Meyer, G. J. Netto, D. Bell, K. H. Little, L. Ferries, C. A. Santa Ana, J. L. Porter & J. S. Fordtran: Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. New. Engl. J. Med. 2001, 344, 270274.
  • Hoosein, N. M., P. A. Kiener, R. C. Curry & M. G. Brattain: Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp. Cell Res. 1990, 186, 1521.
  • Hoosein, N. M., P. A. Kiener, R. C. Curry, L. C. Rovatti, D. K. McGilbra & M. G. Brattain: Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res. 1988, 48, 71797183.
  • Håkanson, R., G. Böttcher, F. Sundler & S. Vallgren: Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach. Digestion 1986, 1, 2341.
  • Håkanson, R., D. Chen & F. Sundler: The ECL cells. In: Physiology of the gastrointestinal tract. Ed.: L. R.Johnson. Raven Press, New York, NY, USA, 1994, pp. 11711184.
  • Håkanson, R., X. Q. Ding, P. Norlén & E. Lindström: CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis. Regul. Pept. 1999, 80, 112.
  • Håkanson, R. & F. Sundler: Mechanisms for the development of gastric carcinoids. Digestion 1986, (Suppl 1)35, 1151.
  • Isaksson, G. & I. Ihse: Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig. Dis. Sci. 1983, 28, 97102.
  • Ivy, A. C. & E. Oldberg: A hormone mechanism for gallbladder contraction and evacuation. Amer. J. Physiol. 1928, 65, 599613.
  • Iwase, K., B. M. Evers, M. R. Hellmich, Y. S. Guo, S. Higashide, H. J. Kim & C. M. Townsend, Jr.: Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997, 113, 782790.
  • Jansen, J. B., E. C. Klinkenberg-Knol, S. G. Meuwissen, J. W. De Bruijne, H. P. Festen, P. Snel, A. E. Luckers, I. Biemond & C. B. Lamers: Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990, 99, 621628.
  • Jensen, R. T.: Gastrinoma as a model for prolonged hypergastrinemia in man. In: Gastrin.. Ed.: J. H.Walsh. Raven Press Publishing Co., New York, NY, USA, 1993, pp. 373393.
  • Jensen, R. T.: Receptors on pancreatic acinar cells. In: Physiology of the gastrointestinal tract, 3rd ed. Vol. 2. Eds.: L. R.Johnson, E. D.Jacobson, J.Christensen, D. H.Alpers & J. H.Walsh. Raven Press, New York, NY, USA, 1994, pp. 13771446.
  • Jensen, R. T.: Gastrinoma. Bailliere's Clin. Gastroenterol. 1996, 10, 555766.
  • Jensen, R. T.: Gastrin-producing tumors. Cancer Treat. Res. 1997, 89, 293334.
  • Jensen, R. T.: Zollinger-Ellison syndrome. In: Surgical endocrinology: Clinical syndromes, Eds.: G. M.Doherty & B.Skogseid. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2001, pp. 291344.
  • Jensen, R. T. & J. D. Gardner: Gastrinoma. In: The pancreas: Biology, pathobiology and disease. Eds.: V. L. W.Go, E. P.DiMagno, J. D.Gardner, E.Lebenthal, H. A.Reber & G. A.Scheele. Raven Press Publishing Co., New York, NY, USA, 1993, pp. 931978.
  • Jensen, R. T., S. A. Wank, W. H. Rowley, S. Sato & J. D. Gardner: Interaction of CCK with pancreatic acinar cells. Trends Pharmacol. Sci. 1989, 10, 418423.
  • Ji, B., Y. Bi, D. Simeone, R. M. Mortensen & C. D. Logsdon: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 2001, 121, 13801390.
  • Jin, H. O., C. W. Song, T. M. Chang & W. Y. Chey: Roles of gut hormones in negative-feedback regulation of pancreatic exocrine secretion in humans. Gastroenterology 1994, 107, 18281834.
  • Jorpes, J. E. & V. Mutt: Handbook of experimental pharmacology. Secretin, cholecystokinin, pancreozymin. Springer-Verlag, Berlin, Heidelberg, Germany, 1973.
  • Katz, M., R. Carangelo, L. J. Miller & F. Gorelick: Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Amer. J. Physiol. 1996, 270, G171G175.
  • Kellow, J. E., S. F. Phillips, L. J. Miller & A. R. Zinsmeister: Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988, 29, 12361243.
  • Kochman, M. L., J. DelValle, C. J. Dickinson & C. R. Boland: Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem. Biophys. Res. Commun. 1992, 189, 11651169.
  • Koh, T. J. & D. Chen: Gastrin as a growth factor in the gastrointestinal tract. Regul. Pept. 2000, 25, 3744.
  • Koh, T. J., G. J. Dockray, A. Varro, R. J. Cahill, C. A. Dangler, J. G. Fox & T. C. Wang: Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J. Clin. Invest. 1999, 103, 11191126.
  • Konturek, J. W., A. Gillessen, S. J. Konturek & W. Domschke: Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995a, 37, 482487.
  • Konturek, J. W., S. J. Konturek & W. Domschke: Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand. J. Gastroenterol. 1995b, 30, 738744.
  • Kovacs, T. O., J. H. Walsh, V. Maxwell, H. C. Wong, T. Azuma & E. Katt: Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology 1989, 97, 14061413.
  • Kreiss, C., W. Schwizer, J. Borovicka, J. B. Jansen, C. Bouloux, R. Pignol, A. Bischof Delaloye & M. Fried: Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans. Regul. Pept. 1998, 74, 143149.
  • Lacourse, K. A., L. J. Swanberg, P. J. Gillespie, J. F. Rehfeld, T. L. Saunders & L. C. Samuelson: Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Amer. J. Physiol. 1999, 276, G1302G1309.
  • Laghi, L., G. N. Ranzani, P. Bianchi, A. Mori, K. Heinimann, O. Orbetegli, M. R. Spaudo, O. Luinetti, S. Francisconi, M. Roncalli, E. Solcia & A. Malesci: Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability. Lab. Invest. 2002, 82, 265271.
  • Lamberts, R., W. Creutzfeldt, F. Stockmann, U. Jacubaschke, S. Maas & G. Brunner: Long term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion 1988, 39, 126135.
  • Lamberts, R., W. Creutzfeldt, H. G. Struber, G. Brunner & E. Solcia: Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993, 104, 13561370.
  • Lamers, C. B., J. B. Jansen & R. A. Woutersen: Cholecystokinin and gastrointestinal cancer. J. Steroid Biochem. Mol. Biol. 1990, 37, 10691072.
  • Langhans, N., G. Rindi, M. Chiu, J. F. Rehfeld, B. Ardman, M. Beinborn & A. S. Kopin: Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997, 112, 280286.
  • Larsson, H., E. Carlsson, H. Mattsson, L. Lundell, F. Sundler, G. Sundell, B. Wallmark, T. Watanabe & R. Håkanson: Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986, 90, 391399.
  • LeDrean, G., I. LeHuerou-Luron, M. Gestin, C. Desbois, V. Rome, C. Bernard, M. Dufresne, L. Moroder, D. Gully, J. A. Chayvialle, D. Fourmy & P. Guilloteau: Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf. Pflügers Arch. 1999, 438, 8693.
  • Lehy, T., G. Cadiot, M. Mignon, P. Ruszniewski & S. Bonfils: Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992, 33, 12751279.
  • Lehy, T., M. Mignon, G. Cadiot, L. Elouaer-Blanc, P. Ruszniewski, M. J. Lewin & S. Bonfils: Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 1989, 96, 10291040.
  • Lembcke, B., W. Creutzfeldt, S. Schleser, R. Ebert, C. Shaw & I. Koop: Effect of the somatostatin analogue sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987, 36, 108124.
  • LeMeuth, V., V. Philouze-Rome, I. LeHuerou-Luron, M. Formal, N. Vaysse, C. Gespach, P. Guilloteau & D. Fourmy: Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas. Endocrinology 1993, 133, 11821191.
  • Levi, S., K. Beardshall, G. Haddad, R. Playford, P. Ghosh & J. Calam: Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989, 1, 11671168.
  • Lewin, M. J. & A. Bado: Gastric leptin. Microsc. Res. Tech. 2001, 53, 372376.
  • Liddle, R. A.: Cholecystokinin. In: Gut peptides, Eds.: J. H.Walsh & G. J.Dockray. Raven Press, New York, NY, USA, 1994, pp. 175216.
  • Lieverse, R. J., J. B. Jansen, A. A. Masclee & C. B. Lamers: Satiety effects of a physiological dose of cholecystokinin in humans. Gut 1995a, 36, 176179.
  • Lieverse, R. J., J. B. Jansen, A. M. Masclee & C. B. Lamers: Satiety effects of cholecystokinin in humans. Gastroenterology 1994, 106, 14511454.
  • Lieverse, R. J., A. A. Masclee, J. B. Jansen, L. C. Rovati & C. B. Lamers: Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women. Biol. Psychiatry 1995b, 37, 331335.
  • Ligumsky, M., J. Lysy, G. Siguencia & Y. Friedländer: Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis. J. Clin. Gastroenterol. 2001, 33, 3235.
  • Lillemoe, K. D.: Chronic acalculous cholecystitis: are we diagnosing a disease or a myth? Radiology 1997, 204, 1314.
  • Lindström, E., D. Chen, P. Norlén, K. Andersson & R. Håkanson: Control of gastric acid secretion: the gastrin-ECL cell-parietal cell axis. Comput. Med. Imaging Graph. 2001, 128, 505514.
  • Ling, P. R., M. Sheikh, P. Boyce, M. Keane-Ellison & A. Thibault: Cholecystokinin (CCK) secretion in patients with severe short bowel syndrome. Dig. Dis. Sci. 2001, 46, 859864.
  • Low-Beer, T. S., R. F. Harvey, E. R. Davies & A. F. Read: Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease. New. Engl. J. Med. 1975, 292, 961963.
  • Malesci, A., E. Gaia, A. Fioretta, P. Bocchia, G. Ciravegna, P. Cantor & I. Vantini: No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand. J. Gastroenterol. 1995, 30, 392398.
  • Mandair, K. K., P. Towner, I. F. Stamford, J. D. Morris, E. Harper, I. S. Benjamin & I. A. Tavares: Cholecystokinin receptors in human pancreatic cancer cell lines. Eur. J. Cancer 1998, 34, 14551459.
  • Marchal-Victorion, S., N. Vionnet, C. Escrieut, F. Dematos, C. Dina, M. Dufresne, N. Vaysse, L. Pradayrol, P. Froguel & D. Fourmy: Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics 2002, 12, 2330.
  • Masclee, A. A., J. B. Jansen, W. M. Driessen, L. M. Geuskens & C. B. Lamers: Gallbladder sensitivity to cholecystokinin in celiac disease. Correlation of gallbladder contraction with plasma cholecystokinin-like immunoreactivity during infusion of cerulein. Scand. J. Gastroent. 1991, 26, 12791284.
  • Maton, P.: Risks of hypergastrinemia. Dig. Dis. Sci. 1995, 13, 12.
  • Maton, P. N., E. E. Lack, M. J. Collen, M. J. Cornelius, E. David, J. D. Gardner & R. T. Jensen: The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. Gastroenterology 1990, 99, 943950.
  • Maton, P. N., S. M. Mackem, J. A. Norton, J. D. Gardner, T. M. O'Dorisio & R. T. Jensen: Ovarian carcinoma as a cause of Zollinger-Ellison syndrome. Natural history, secretory products and response to provocative tests. Gastroenterology 1989, 97, 468471.
  • Matson, C. A., D. F. Reid, T. A. Cannon & R. C. Ritter: Cholecystokinin and leptin act synergistically to reduce body weight. Amer. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278, R882R890.
  • Matson, C. A., M. F. Wiater, J. L. Kuijper & D. S. Weigle: Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 1997, 18, 12751278.
  • Mattsson, H., N. Havu, J. Bräutigam, K. Carlsson, L. Lundell & E. Carlsson: Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology 1991, 100, 311319.
  • Matzinger, D., J. P. Gutzwiller, J. Drewe, A. Orban, R. Engel, M. D'Amato, L. Rovati & C. Beglinger: Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Amer. J. Physiol. 1999, 277, R1718R1724.
  • McColl, K. E., D. Gillen & E. El-Omar: The role of gastrin in ulcer pathogenesis. Baillieres Best Pract. Res. Clin. Gastroenterol. 2000, 14, 1326.
  • McWilliams, D. F., S. A. Watson, D. M. Crosbee, D. Michaeli & R. Seth: Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut 1998, 42, 795798.
  • Meier, R., C. Beglinger, M. Thumshirn, B. Meyer, L. C. Rovati, G. Giacovelli, M. D'Amato & K. Gyr: Therapeutic effects of loxiglumide, a cholecystokinin antagonist, on chronic constipation in elderly patients: a prospective, randomized, double-blind, controlled trial. J. Gastrointest. Mot. 1993, 5, 129135.
  • Metz, D. C., H. C. Weber, M. Orbuch, D. B. Strader, I. A. Lubensky & R. T. Jensen: Helicobacter pylori infection: a reversible cause of hypergastrinemia and hyperchlorhydria which can mimic Zollinger-Ellison syndrome. Dig. Dis. Sci. 1995, 40, 153159.
  • Meyer-Wyss, B., B. Werth & C. Belinger: Regulation of gastrointestinal and colonic transit by CCK antagonists. In: Cholecystokinin antagonists in gastroenterology. Eds.: G.Adler & C.Beglinger. Springer-Verlag, Berlin, Germany, 1991, pp. 183193.
  • Meyer, B. M., B. A. Werth, C. Beglinger, P. Hildebrand, J. B. Jansen, D. Zach, L. C. Rovati & G. A. Stalder: Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet .
  • Middleton, G. W. & J. H. Williams: Diagnostic accuracy of 99Tcm-HIDA with cholecystokinin and gallbladder ejection fraction in acalculous gallbladder disease. Nucl. Med. Commun. 2001, 22, 657661.
  • Mignon, M., P. Jais, G. Cadiot, D. Yedder & J. Vatier: Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome. In: Endocrine tumors of the pancreas: Recent advances in research and management. Series: Frontiers of gastrointestinal research, Vol. 23. Eds.: M.Mignon & R. T.Jensen. S. Karger, Basel, Switzerland, 1995, pp. 223239.
  • Militello, C., C. Sperti, F. DiPrima & S. Pedrazzoli: Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group. Pancreas 1997, 14, 222228.
  • Miller, L. J., E. L. Holicky, C. D. Ulrich & E. D. Weiben: Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 1995, 109, 13751380.
  • Miyasaka, K., H. Shinozaki, S. Suzuki, Y. Sato, S. Kanai, M. Masuda, A. Jimi, A. Nagata, T. Matsui, T. Noda, A. Kono & A. Funakoshi: Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth: a study in CCK-B receptor gene knockout mice. Pancreas 1999, 19, 114118.
  • Modlin, I. M. & L. H. Tang: The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology 1996, 111, 783810.
  • Monstein, H. J., A. G. Nylander, A. Salehi, D. Chen, I. Lundquist & R. Håkanson: Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gatrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand. J. Gastroent. 1996, 31, 383390.
  • Monstein, H. J., B. Ohlsson & J. Axelson: Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. Scand. J. Gastroenterol. 2001, 36, 738743.
  • Moonka, R., W. Zhou & R. H. Bell, Jr.: Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. J. Gastrointest. Surg. 1999, 3, 134140.
  • Moran, T. H.: Cholecystokinin and satiety: current perspectives. Nutrition 2000, 16, 858865.
  • Morisset, J., F. Levenez, T. Corring, O. Benrezzak, G. Pelletier & E. Calvo: Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype. Amer. J. Physiol. 1996, 27, E397E402.
  • Morisset, J., H. Wong, J. H. Walsh, J. Laine & J. Bourassa: Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation. Amer. J. Physiol. (Gastrointest. Liver Physiol. 1) 2000, 279, G148G156.
  • Morris, D. L., R. M. Charnley, K. C. Ballantyne & J. Jones: A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer. Eur. J. Surg. Oncol. 1990, 16, 423425.
  • Moss, S. F., S. Legon, A. E. Bishop, J. M. Polak & J. Calam: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992, 340, 930932.
  • Mossner, J.: Palliation of pain in chronic pancreatitis. Surg. Clin. North Am. 1999, 79, 861872.
  • Mossner, J., R. Secknus, J. Meyer, C. Niederau & G. Adler: Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion 1992, 53, 5466.
  • Mutt, V. & J. E. Jorpes: Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur. J. Biochem. 1968, 6, 156162.
  • Nagata, A., M. Ito, N. Iwata, J. Kuno, H. Takano, O. Minowa, K. Chihara, T. Matsui & T. Noda: G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. (USA) 1996, 93, 1182511830.
  • Neiderau, C., R. Luthen & T. Heintges: Effects of CCK on pancreatic function and morphology. Ann. N. Y. Acad. Sci. 1994, 713, 180198.
  • Neuburger, P., M. Lewin, C. d. Recherche & S. Bonfils: Parietal and chief cell population in four cases of the Zollinger-Ellison syndrome. Gastroenterology 1972, 63, 937942.
  • Niederau, C., L. D. Ferrell & J. H. Grendell: Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985, 88, 11921204.
  • Niederau, C. & J. H. Grendell: Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists. Digestion 1999, 60, 6974.
  • Niederau, C., R. A. Liddle, L. D. Ferrell & J. H. Grendell: Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J. Clin. Invest. 1986, 78, 10561063.
  • Nishimori, I., M. Kamakura, K. Fujikawa-Adachi, M. Nojima, S. Onishi, M. A. Hollingsworth & A. Harris: Cholecystokinin A and B receptor mRNA expression in human pancreas. Pancreas 1999, 19, 109113.
  • Noda, S., J. A. Norton, R. T. Jensen & W. A. Gay, Jr.: Surgical resection of intracardiac gastrinoma. Ann. Thorac. Surg. 1999, 67, 532533.
  • Ochi, K., H. Harada & K. Satake: Clinical evaluation of cholecystokinin-A- receptor antagonist (loxiglumide) for the treatment of acute pancreatitis. A preliminary clinical trial. Study Group of Loxiglumide in Japan. Digestion 1999, 60, 8185.
  • Ohlsson, B., J. Axelson, B. Sternby, J. F. Rehfeld & I. Ihse: Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor. Int. J. Pancreatol. 1995, 18, 5966.
  • Ohlsson, B., K. Borg, J. F. Rehfeld, I. Ihse & J. Axelson: The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas. Int. J. Pancreatol. 1998, 24, 211218.
  • Ohlsson, B., N. Fredang & J. Axelson: The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Scand. J. Gastroenterol. 1999a, 34, 12241229.
  • Ohlsson, B., J. F. Rehfeld & J. Axelson: CCK stimulates growth of both the pancreas and the liver. Int. J. Surg. Investig. 1999b, 1, 4754.
  • Okada, N., A. Kubota, T. Imamura, H. Suwa, Y. Kawaguchi, G. Ohshio, Y. Seino & M. Imamura: Evaluation of cholecystokinin, gastrin, CCK-A, receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer. Cancer Lett. 1996, 106, 257262.
  • Orbuch, M., D. J. Venzon, I. A. Lubensky, H. C. Weber, F. Gibril & R. T. Jensen: Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Dig. Dis. Sci. 1996, 41, 604613.
  • Otsuki, M.: Pathophysiological role of cholecystokinin in humans. J. Gastroenterol. Hepatol. 2000, 15, D71D83.
  • Ott, D. J.: Acalculous gallbladder disease: a controversial entity and imaging dilemma revisited. Amer. J. Gastroenterol. 1998, 93, 11811183.
    Direct Link:
  • Pandol, S. J., S. Periskic, I. Gukovsky, V. Zaninovic & Y. Jung: Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology 1999, 117, 706716.
  • Peghini, P. L., B. Annibale, C. Azzoni, M. Milione, V. D. Corleto, F. Gibril, D. J. Venzon, G. Delle Fave, C. Bordi & R. T. Jensen: Effect of long-term hypergastrinemia on human ECL cells: insights from patients with sporadic gastrinomas. Gastroenterology 2002, 123, 6885.
  • Penman, I. D., E. El-Omar, J. E. Ardill, J. R. McGregor, D. J. Galloway, P. J. O'Dwyer & K. E. McColl: Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 1994, 106, 12631270.
  • Philippe, C., E. F. Lhoste, M. Dufresne, L. Moroder, T. Corring & D. Fourmy: Pharmacological and biochemical evidence for the simultaneous expression of CCKB/gastrin and CCKA receptors in the pig pancreas. Brit. J. Pharmacol. 1997, 120, 447454.
  • Polacek, M. A. & E. H. Ellison: Parietal cell mass and gastric acid secretion in the Zollinger-Ellison syndrome. Surgery 1966, 60, 606614.
  • Poynter, D., C. R. Pick, R. A. Harcourt, S. A. Selway, G. Ainge, I. W. Harman, N. W. Spurling, P. A. Fluck & J. L. Cook: Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut 1985, 26, 12841295.
  • Poynter, D., S. A. Selway, S. A. Papworth & S. R. Riches: Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. Gut 1986, 27, 13381346.
  • Rayner, C. K., H. S. Park, S. M. Doran, I. M. Chapman & M. Horowitz: Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycemia. Amer. J. Physiol. Gastrointest. Liver Physiol. 2000, 278, G98G104.
  • Rehfeld, J. F.: Gastrin and colorectal cancer: A never-ending dispute? (Editorial). Gastroenterology 1995, 108, 13071310.
  • Rehfeld, J. F. & W. W. Van Solinge: The tumor biology of gastrin and cholecystokinin. Adv. Cancer Res. 1994, 63, 295347.
  • Reidelberger, R. D.: Cholecystokinin and control of food intake. J. Nutr. 1994, 124, 1327S1333S.
  • Reitter, D. & H. L. Aaning: Chronic acalculous cholecystitis: reproduction of pain with cholecystokinin and relief of symptoms with cholecystectomy. South Dakota J. of Medicine 1999, 52, 197200.
  • Renga, M., G. Brandi, G. M. Paganelli, C. Calabrese, S. Papa, A. Tosti, P. Tomassetti, M. Miglioli & G. Biasco: Rectal cell proliferation and colon cancer risk in patients with hypergastrinemia. Gut 1997, 41, 330332.
  • Reubi, J. C., J. C. Schaer & B. Waser: Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997, 57, 13771386.
  • Rindi, G., C. Azzoni, S. La Rosa, C. Klersy, D. Paolotti, S. Rappel, M. Stolte, C. Capella, C. Bordi & E. Solcia: ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999, 116, 532542.
  • Rindi, G., C. Bordi, S. Rappel, S. La Rosa, M. Stolte & E. Solcia: Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J. Surg. 1996, 20, 168172.
  • Rosenlund, M. L.: The Zollinger-Ellison syndrome in children. A review. Amer. J. Med. Sci. 1967, 254, 884892.
  • Roy, P., D. J. Venzon, K. M. Feigenbaum, P. D. Koviack, S. Bashir, J. V. Ojeaburu, F. Gibril & R. T. Jensen: Gastric secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis – A prospective NIH study of 235 patients and review of the literature in 984 cases. Medicine (Baltimore) 2001, 80, 189222.
  • Roy, P., D. J. Venzon, H. Shojamanesh, A. Abou-Saif, P. Peghini, J. L. Doppman, F. Gibril & R. T. Jensen: Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 2000, 79, 379411.
  • Rozengurt, E. & J. H. Walsh: Gastrin, CCK, signaling, and cancer. Annu. Rev. Physiol. 2001, 63, 4976.
  • Ryberg, B., J. Axelson, R. Håkanson, F. Sundler & H. Mattsson: Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology 1990, 98, 3338.
  • Saillan-Barreau, C., M. Dufresne, P. Clerc, D. Sanchez, H. Corominola, C. Moriscot, O. Guy-Crotte, C. Escrieut, N. Vaysse, R. Gomis, N. Tarasova & D. Fourmy: Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 1999, 48, 20152021.
  • Schmidt, W. E., W. Creutzfeldt, A. Schleser, A. R. Choudhury, R. Nustede, M. Hocker, R. Nitsche, H. Sostmann, L. C. Rovati & U. R. Folsch: Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Amer. J. Physiol. 1991, 260, G197G206.
  • Schmidt, W. E., S. Schenk, R. Nustede, J. J. Holst, U. R. Folsch & W. Creutzfeldt: Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 1994, 107, 16101620.
  • Schmitz, F., J. M. Otte, H. U. Stechele, B. Reimann, T. Banasiewicz, U. R. Folsch, W. E. Schmidt & K. H. Herzig: CCK-B/gastrin receptors in human colorectal cancer. Eur. J. Clin. Invest. 2001, 31, 812820.
  • Schweiger, M., M. H. Erhard & W. M. Amelgruber: Cell-specific localization of the cholecystokininA receptor in the porcine pancreas. Anat. Histol. Embryol. 2000, 29, 357361.
  • Schwizer, W., J. Borovicka, P. Kunz, R. Fraser, C. Kreiss, M. D'Amato, G. Crelier, P. Boesiger & M. Friend: Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997, 41, 500504.
  • Seva, C., C. J. Dickinson & T. Yamada: Growth-promoting effects of glycine-extended progastrin. Science 1994, 265, 410412.
  • Shoji, E., T. Okumura, S. Onodera, N. Takahashi, K. Harada & Y. Kohgo: Gastric emptying in OLETF rats not expressing CCK-A receptor gene. Dig. Dis. Sci. 1997, 42, 915919.
  • Shulkes, A. & G. S. Baldwin: Biology of gut cholecystokinin and gastrin receptors. Clin. Exp. Pharmacol. Physiol. 1997, 24, 209216.
  • Singh, P., A. Owlia, A. Varro, B. Dai, S. Rajaraman & T. Wood: Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res. 1996, 56, 41114115.
  • Singh, P., B. Rae-Venter, C. M. Townsend, Jr., T. Khalil & J. C. Thompson: Gastrin receptors in normal and malignant gastrointestinal mucosa: age-associated changes. Amer. J. Physiol. 1985, 249, G761G769.
  • Sjölund, K., R. Ekman, S. Lindgren & J. F. Rehfeld: Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand. J. Gastroenterol. 1996, 31, 11101114.
  • Slaff, J., D. Jacobson, C. R. Tillman, C. Curington & P. Toskes: Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984, 87, 4452.
  • Smith, A. M., T. Justin, D. Michaeli & S. A. Watson: Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer. Clin. Cancer Res. 2000, 6, 47194724.
  • Smith, A. M. & S. A. Watson: Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000a, 47, 820824.
  • Smith, A. M. & S. A. Watson: Review article: gastrin and colorectal cancer. Aliment. Pharmacol. Ther. 2000b, 14, 12311247.
  • Smith, J. P., A. P. Fantaskey, G. Liu & I. S. Zagon: Identification of gastrin as a growth peptide in human pancreatic cancer. Amer. J. Physiol. 1995, 268, R135R141.
  • Smith, J. P. & T. E. Solomon: Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988, 95, 15411548.
  • Smith, J. P., J. G. Wood & T. E. Solomon: Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig. Dis. Sci. 1989, 34, 171174.
  • Smythe, A., A. W. Majeed, M. Fitzhenry & A. G. Johnson: A requiem for the cholecystokinin provocation test? Gut 1998, 43, 571574.
  • Snape, W. J., Jr., G. M. Carlson, S. A. Matarazzo & S. Cohen: Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome. Gastroenterology 1977, 72, 383387.
  • Sobhani, I., T. Lehy, P. Laurent-Puig, G. Cadiot, P. Ruszniewski & M. Mignon: Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 1993, 105, 2230.
  • Solcia, E., C. Bordi, W. Creutzfeldt, Y. Dayal, A. D. Dayan, S. Falkmer, L. Grimelius & N. Havu: Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988, 41, 185200.
  • Solcia, E., C. Capella, F. Sessa, S. Rindi, M. Cornaggia, C. Riva & L. Villani: Gastric carcinoids and related endocrine growths. Digestion 1986, 35(Suppl 1), 322.
  • Solcia, E., R. Fiocca, L. Villani, A. Gianatti, M. Cornaggia, A. Chiaravalli, M. Curzio & C. Capella: Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand. J. Gastroenterol. 1991, 26, 146159.
  • Solcia, E., G. Rindi, S. LaRosa & C. Capella: Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc. Res. Tech. 2000, 48, 339348.
  • Solcia, E., G. Rindi, E. Silini & L. Villani: Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. Baillieres Clin. Gastroenterol. 1993, 7, 149165.
  • Soll, A. H.: Peptic ulcer and its complications. In: Gastrointestinal and liver disease. Eds.: M.Feldman, M. H.Sleisenger & B. F.Scharschmidt. W.B. Saunders Co, Philadelphia, PA, USA, 1998, pp. 620678.
  • Solomon, T. E., H. Petersen, J. Elashoff & M. I. Grossman: Interaction of caerulein and secretin on pancreatic size and composition in rat. Amer. J. Physiol. 1978, 235, E714E719.
  • Soudah, H. C., Y. A. Lu, W. L. Hasler & C. Owyang: Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Amer. J. Physiol. 1992, 263, G102G107.
  • Steer, M. L.: Early events in acute pancreatitis. Baillieres Best Pract. Res. Clin. Gastroenterol. 1999, 13, 213225.
  • Strasberg, S. M.: Acute acalculus cholecystitis. Gastroenterology 1995, 26652673.
  • Sum, P. & B. J. Perey: Parietal-cell mass (PCM) in a man with Zollinger-Ellison syndrome. Can. J. Surg. 1969, 12, 285288.
  • Sundler, F., R. Håkanson, E. Carlsson, H. Larsson & H. Mattsson: Hypergastrinemia after blockade of acid secretion in the rat: trophic effects. Digestion 1986, 35, 5669.
  • Suzuki, H., K. Matsumoto & H. Terashima: Serum levels of gastrin in patients with colorectal neoplasia. Dis. Colon Rectum. 1988, 32, 716717.
  • Suzuki, S., S. Takiguchi, N. Sato, S. Kanai, T. Kawanami, Y. Yoshida, K. Miyasaka, Y. Takata, A. Funakoshi & T. Noda: Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice. Jap. J. Physiol. 2001, 51, 585590.
  • Szabo, I., G. Rumi, B. Bodis, P. Nemeth & G. Mozsik: Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells. J. Physiol. (Paris) 2000, 94, 7174.
  • Tachibana, I., H. Shirohara, L. Czako, T. Akiyama, S. Nakano, N. Watanabe, Y. Hirohata & M. Otsuki: Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats. Pancreas 1997, 14, 113121.
  • Takiguchi, S., S. Suzuki, Y. Sato, S. Kanai, K. Miyasaka, A. Jimi, H. Shinozaki, Y. Takata, A. Funakoshi, A. Kono, O. Minowa, T. Kobayashi & T. Noda: Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice. Pancreas 2002, 24, 276283.
  • Teich, N., J. Ockenga, A. Hoffmeister, M. Manns, J. Mossner & V. Keim: Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000, 119, 461465.
  • Thorburn, C. M., G. D. Friedman, C. J. Dickinson, J. H. Vogelman, N. Orentreich & J. Parsonnet: Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998, 115, 275280.
  • Toskes, P. P.: Feedback control of pancreatic exocrine secretion. Trans. Am. Clin. Climatol. Assoc. 2001, 112, 6167.
  • Townsend, C. M., Jr., P. Singh & J. C. Thompson: Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol. Clin. North Am. 1989, 18, 777791.
  • Trotman, I. F. & C. C. Price: Bloated irritable bowel syndrome defined by dynamic 99mTc bran scan. Lancet 1986, 2, 364366.
  • Van Solinge, W. W., L. Odum & J. F. Rehfeld: Ovarian cancers express and process progastrin. Cancer Res. 1993, 53, 18231828.
  • Walsh, J. H.: Gastrin. In: Gut peptides. Eds.: J. H.Walsh & G. J.Dockray. Raven Press, New York, NY, USA, 1994, pp. 75121.
  • Wang, T. C. & G. J. Dockray: Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice. Amer. J. Physiol. 1999, 277, G6G11.
  • Wang, T. C., T. J. Koh, A. Varro, R. J. Cahill, C. A. Dangler, J. G. Fox & G. J. Dockray: Processing and proliferative effects of human progastrin in transgenic mice. J. Clin. Invest. 1996, 98, 19181929.
  • Wangberg, B., O. Nilsson, E. Theodorsson, I. M. Modlin, A. Dahlström & H. Ahlman: Are enterochromaffinlike cell tumours reversible? An experimental study on gastric carcinoids induced in Mastomys by histamine2-receptor blockade. Regul. Pept. 1995, 56, 1933.
  • Wank, S. A.: Cholecystokinin receptors. Amer. J. Physiol. 1995, 269, G628G646.
  • Wank, S. A., J. R. Pisegna & A. DeWeerth: Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann. N. Y. Acad. Sci. 1994, 713, 4966.
  • Watson, S. A., P. A. Clarke, T. M. Morris & M. E. Caplin: Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor. Cancer Res. 2000, 60, 59025907.
  • Watson, S. A. & A. D. Gilliam: G17DT–a new weapon in the therapeutic armoury for gastrointestinal malignancy. Expert Opin. Biol. Ther. 2001, 1, 309317.
  • Watson, S. A. & A. M. Smith: Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res. 2001, 61, 625631.
  • Weinberg, D. S., B. Ruggeri, M. T. Barber, S. Biswas, S. Miknyocki & S. A. Waldman: Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinomas. J. Clin. Invest. 1997, 100, 597603.
  • Whitcomb, D. C.: Early trypsinogen activation in acute pancreatitis. Gastroenterology 1999, 116, 770772.
  • Whitcomb, D. C., M. C. Gorry, R. A. Preston, W. Furey, M. J. Sossenheimer, C. D. Ulrich, S. P. Martin, L. K. Gates, Jr., S. T. Amann, P. P. Toskes, R. A. Liddle, K. McGrath, G. Uomo, J. C. Post & G. D. Ehrlich: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 1996, 14, 141145.
  • Whitcomb, D. C. & C. D. 2. Ulrich: Hereditary pancreatitis: new insights, new directions. Baillieres Best Pract. Res. Clin. Gastroenterol. 1999, 13, 253263.
  • Wiley, J. & C. Owyang: Participation of serotonin and substance P in the action of cholecystokinin on colonic motility. Amer. J. Physiol. 1987, 252, G431G435.
  • Xiao, Z. L., Q. Chen, J. Amaral, P. Biancani & J. Behar: Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Amer. J. Physiol. (Gastrointest. Liver Physiol.) 2000, 278, G251G258.
  • Xiao, Z. L., Q. Chen, J. Amaval, P. Biancani, R. T. Jensen & J. Behar: CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Amer. J. Physiol. 1999, 276, G401G407.
  • Yapp, R., I. M. Modlin, R. R. Kumar, H. J. Binder & R. Dubrow: Gastrin and colorectal cancer. Evidence against an association. Dig. Dis. Sci. 1992, 37, 481484.
  • Zhou, W., S. P. Povoski & R. H. Bell, Jr.: Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. J. Surg. Res. 1995, 58, 281289.
  • Ziessman, H. A.: Cholecystokinin cholescintigraphy: victim of its own success? J. Nucl. Med. 1999, 40, 20382042.
  • Ziessman, H. A.: Cholecystokinin cholescintigraphy: Clinical indications and proper methodology. Radiol. Clin. North Am. 2001, 39, 997.
  • Ziessman, H. A., L. R. Muenz, A. K. Agarwal & A. A. M. ZaZa: Normal values for sincalide cholescintigraphy: comparison of two methods. Radiology 2001, 221, 404410.
  • Zucker, K. A., T. E. Adrian, A. J. Bilchik & I. M. Modlin: Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Amer. J. Physiol. 1989, 257, G511G516.